![Alliance for Clinical Trials in Oncology(@ALLIANCE_org) 's Twitter Profileg](https://pbs.twimg.com/profile_images/878308920573526016/AiPxLHWi_200x200.jpg)
Alliance for Clinical Trials in Oncology
@ALLIANCE_org
Utilizing the best science to develop promising new cancer therapies and prevention strategies for cancer.
ID:246919821
http://www.AllianceNCTN.org/ 03-02-2011 18:46:01
4,7K Tweets
7,4K Followers
562 Following
Follow People
![CDC Cancer(@CDC_Cancer) 's Twitter Profile Photo CDC Cancer(@CDC_Cancer) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1506685797247901698/6x1taJh1_200x200.jpg)
![Alliance for Clinical Trials in Oncology(@ALLIANCE_org) 's Twitter Profile Photo Alliance for Clinical Trials in Oncology(@ALLIANCE_org) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/878308920573526016/AiPxLHWi_200x200.jpg)
For #TrialTuesday , Brian Van Tine Washington U. Med leads Alliance for Clinical Trials in Oncology A092104, a trial for patients with advanced uterine #leiomyosarcoma after chemotherapy has stopped working. To learn more, visit bit.ly/Alliance-A0921… #NCI #NCTN Nat'l LMS Foundation Sarcoma Alliance
![Alliance for Clinical Trials in Oncology (@ALLIANCE_org) on Twitter photo 2024-05-07 13:35:13 For #TrialTuesday, @bvantine1 @WUSTLmed leads @ALLIANCE_org A092104, a trial for patients with advanced uterine #leiomyosarcoma after chemotherapy has stopped working. To learn more, visit bit.ly/Alliance-A0921… #NCI #NCTN @NationalLMSF @SarcomaAlliance For #TrialTuesday, @bvantine1 @WUSTLmed leads @ALLIANCE_org A092104, a trial for patients with advanced uterine #leiomyosarcoma after chemotherapy has stopped working. To learn more, visit bit.ly/Alliance-A0921… #NCI #NCTN @NationalLMSF @SarcomaAlliance](https://pbs.twimg.com/media/GM-tvChXEAEpT3q.png)
![Alliance for Clinical Trials in Oncology(@ALLIANCE_org) 's Twitter Profile Photo Alliance for Clinical Trials in Oncology(@ALLIANCE_org) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/878308920573526016/AiPxLHWi_200x200.jpg)
#ICYMI - .Alex Shoushtari, MD Memorial Sloan Kettering Cancer Center leads Alliance for Clinical Trials in Oncology A091903, a phase II trial to test whether nivolumab in combination with cabozantinib works in patients with mucosal #melanoma . To learn more, visit bit.ly/Alliance-A0919… #NCI #NCTN #CancerResearch Melanoma Research Foundation
![Alliance for Clinical Trials in Oncology (@ALLIANCE_org) on Twitter photo 2024-05-06 13:35:16 #ICYMI - .@alexshoushtari @MSKCancerCenter leads @ALLIANCE_org A091903, a phase II trial to test whether nivolumab in combination with cabozantinib works in patients with mucosal #melanoma. To learn more, visit bit.ly/Alliance-A0919… #NCI #NCTN #CancerResearch @CureMelanoma #ICYMI - .@alexshoushtari @MSKCancerCenter leads @ALLIANCE_org A091903, a phase II trial to test whether nivolumab in combination with cabozantinib works in patients with mucosal #melanoma. To learn more, visit bit.ly/Alliance-A0919… #NCI #NCTN #CancerResearch @CureMelanoma](https://pbs.twimg.com/media/GM5kJ2_WYAAO3Z0.png)
![LACNETS(@LACNETS) 's Twitter Profile Photo LACNETS(@LACNETS) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1589774531320635393/a_GSOJkI_200x200.jpg)
![CDC Cancer(@CDC_Cancer) 's Twitter Profile Photo CDC Cancer(@CDC_Cancer) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1506685797247901698/6x1taJh1_200x200.jpg)
![Alliance for Clinical Trials in Oncology(@ALLIANCE_org) 's Twitter Profile Photo Alliance for Clinical Trials in Oncology(@ALLIANCE_org) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/878308920573526016/AiPxLHWi_200x200.jpg)
To end Cancer Prevention & Early Detection Month, we highlight Alliance for Clinical Trials in Oncology A212102 MCED Biobank Study that will collect blood & tissue samples from pts w/o cancer to evaluate tests for early cancer detection: bit.ly/AllianceA212102 #NCI #NCORP NCI Prevention & Early Detection CU Cancer Center
![Alliance for Clinical Trials in Oncology (@ALLIANCE_org) on Twitter photo 2024-04-30 20:01:39 To end Cancer Prevention & Early Detection Month, we highlight @ALLIANCE_org A212102 MCED Biobank Study that will collect blood & tissue samples from pts w/o cancer to evaluate tests for early cancer detection: bit.ly/AllianceA212102 #NCI #NCORP @NCIprevention @CUCancerCenter To end Cancer Prevention & Early Detection Month, we highlight @ALLIANCE_org A212102 MCED Biobank Study that will collect blood & tissue samples from pts w/o cancer to evaluate tests for early cancer detection: bit.ly/AllianceA212102 #NCI #NCORP @NCIprevention @CUCancerCenter](https://pbs.twimg.com/media/GMcDDW6WoAA6AIQ.png)
![Alliance for Clinical Trials in Oncology(@ALLIANCE_org) 's Twitter Profile Photo Alliance for Clinical Trials in Oncology(@ALLIANCE_org) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/878308920573526016/AiPxLHWi_200x200.jpg)
On this last day of Cancer Prevention & Early Detection Month, let's take a look at Alliance for Clinical Trials in Oncology A211901, a smoking cessation study for cancer survivors in rural communities, led by .Devon Noonan @DukeU_NrsngSchl - Visit bit.ly/Alliance-A2119… #NCI #NCORP #LCsm NCI Prevention & Early Detection
![Alliance for Clinical Trials in Oncology (@ALLIANCE_org) on Twitter photo 2024-04-30 17:11:38 On this last day of Cancer Prevention & Early Detection Month, let's take a look at @ALLIANCE_org A211901, a smoking cessation study for cancer survivors in rural communities, led by .@noonan_devon @DukeU_NrsngSchl - Visit bit.ly/Alliance-A2119… #NCI #NCORP #LCsm @NCIprevention On this last day of Cancer Prevention & Early Detection Month, let's take a look at @ALLIANCE_org A211901, a smoking cessation study for cancer survivors in rural communities, led by .@noonan_devon @DukeU_NrsngSchl - Visit bit.ly/Alliance-A2119… #NCI #NCORP #LCsm @NCIprevention](https://pbs.twimg.com/media/GMbcI06WsAAcAmy.jpg)
![Vincent Rajkumar(@VincentRK) 's Twitter Profile Photo Vincent Rajkumar(@VincentRK) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1271563144381464576/MYis_acO_200x200.jpg)
Rare group photo from an Intergroup meeting some years ago. ECOG-ACRIN Cancer Research Group SWOG Cancer Research Network Alliance for Clinical Trials in Oncology NRG Oncology National Cancer Institute
A lot of great cancer researchers in this pic.
![Vincent Rajkumar (@VincentRK) on Twitter photo 2024-04-29 17:03:24 Rare group photo from an Intergroup meeting some years ago. @eaonc @SWOG @ALLIANCE_org @NRGonc @theNCI A lot of great cancer researchers in this pic. Rare group photo from an Intergroup meeting some years ago. @eaonc @SWOG @ALLIANCE_org @NRGonc @theNCI A lot of great cancer researchers in this pic.](https://pbs.twimg.com/media/GMWQqMMWoAAoItR.jpg)
![Alliance for Clinical Trials in Oncology(@ALLIANCE_org) 's Twitter Profile Photo Alliance for Clinical Trials in Oncology(@ALLIANCE_org) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/878308920573526016/AiPxLHWi_200x200.jpg)
#ICYMI Dr. Michael Woods Michael Woods Loyola Medicine is leading trial Alliance for Clinical Trials in Oncology A031803 for patients with non-muscle invasive bladder cancer who haven't responded to BCG treatment. To learn more about this trial, visit bit.ly/AllianceA031803 #blcsm #NCI #NCTN
![Alliance for Clinical Trials in Oncology (@ALLIANCE_org) on Twitter photo 2024-04-29 14:57:33 #ICYMI Dr. Michael Woods @mew_uro @LoyolaHealth is leading trial @ALLIANCE_org A031803 for patients with non-muscle invasive bladder cancer who haven't responded to BCG treatment. To learn more about this trial, visit bit.ly/AllianceA031803 #blcsm #NCI #NCTN #ICYMI Dr. Michael Woods @mew_uro @LoyolaHealth is leading trial @ALLIANCE_org A031803 for patients with non-muscle invasive bladder cancer who haven't responded to BCG treatment. To learn more about this trial, visit bit.ly/AllianceA031803 #blcsm #NCI #NCTN](https://pbs.twimg.com/media/GMVz3BwWAAEtw5U.jpg)
![OncoDaily(@oncodaily) 's Twitter Profile Photo OncoDaily(@oncodaily) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1658533540521205764/Y6SV4LWI_200x200.jpg)
The power of the cooperative groups! - Stephanie Berg
Alliance for Clinical Trials in Oncology Toni Choueiri, MD Tian Zhang, MD, MHS Dan George Michael Morris Matt Galsky Jonathan Rosenberg MD
oncodaily.com/56060.html
#ClinicalTrials #Cancer #GenitourinaryOncology #OncoDaily #Oncology
![OncoDaily (@oncodaily) on Twitter photo 2024-04-27 13:36:13 The power of the cooperative groups! - @bergsa83 @ALLIANCE_org @DrChoueiri @TiansterZhang @Daniel_J_George @morr316 @MattGalsky @DrRosenbergMSK oncodaily.com/56060.html #ClinicalTrials #Cancer #GenitourinaryOncology #OncoDaily #Oncology The power of the cooperative groups! - @bergsa83 @ALLIANCE_org @DrChoueiri @TiansterZhang @Daniel_J_George @morr316 @MattGalsky @DrRosenbergMSK oncodaily.com/56060.html #ClinicalTrials #Cancer #GenitourinaryOncology #OncoDaily #Oncology](https://pbs.twimg.com/media/GMLOCwmXUAAPDAA.jpg)
![Tian Zhang, MD, MHS(@TiansterZhang) 's Twitter Profile Photo Tian Zhang, MD, MHS(@TiansterZhang) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1296562199218081793/ORO-FZyU_200x200.jpg)
I remember May 2019 start of #PDIGREE like yest. Am grateful to 750+ NCI CTEP Clinical Research sites, PIs, treating oncologists, & everyone who enrolled & cared for the 1100+ patients on trial. We asked good questions & have much to learn. Thanks Toni Choueiri, MD Dan George Alliance for Clinical Trials in Oncology
![Alliance for Clinical Trials in Oncology(@ALLIANCE_org) 's Twitter Profile Photo Alliance for Clinical Trials in Oncology(@ALLIANCE_org) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/878308920573526016/AiPxLHWi_200x200.jpg)
Happy #ThankYouThursday to our incredible community of researchers, patients, and supporters! Your dedication to advancing cancer research through clinical trials is truly inspiring. Together, we are making a difference in the fight against cancer! #ClinicalTrials #Oncology #NCI
![Alliance for Clinical Trials in Oncology (@ALLIANCE_org) on Twitter photo 2024-04-25 14:02:51 Happy #ThankYouThursday to our incredible community of researchers, patients, and supporters! Your dedication to advancing cancer research through clinical trials is truly inspiring. Together, we are making a difference in the fight against cancer! #ClinicalTrials #Oncology #NCI Happy #ThankYouThursday to our incredible community of researchers, patients, and supporters! Your dedication to advancing cancer research through clinical trials is truly inspiring. Together, we are making a difference in the fight against cancer! #ClinicalTrials #Oncology #NCI](https://pbs.twimg.com/media/GMBA-vWW4AA3tl8.jpg)
![Alliance for Clinical Trials in Oncology(@ALLIANCE_org) 's Twitter Profile Photo Alliance for Clinical Trials in Oncology(@ALLIANCE_org) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/878308920573526016/AiPxLHWi_200x200.jpg)
#DYK : .Thomas Hope UC San Francisco .Sukhmani (Suki) Padda MD Cedars-Sinai are leading a trial (@ALLIANCE_org A021901) that studies the effect of everolimus vesus 177Lu-dotatate in patients with bronchial #neuroendocrine tumors? Learn more: bit.ly/Alliance-A0219… #bronchialcancer #NCI #NCTN .ECOG-ACRIN Cancer Research Group
![Alliance for Clinical Trials in Oncology (@ALLIANCE_org) on Twitter photo 2024-04-24 13:35:18 #DYK: .@thomashopemd @UCSF .@SukiPaddaMD @CedarsSinai are leading a trial (@ALLIANCE_org A021901) that studies the effect of everolimus vesus 177Lu-dotatate in patients with bronchial #neuroendocrine tumors? Learn more: bit.ly/Alliance-A0219… #bronchialcancer #NCI #NCTN .@eaonc #DYK: .@thomashopemd @UCSF .@SukiPaddaMD @CedarsSinai are leading a trial (@ALLIANCE_org A021901) that studies the effect of everolimus vesus 177Lu-dotatate in patients with bronchial #neuroendocrine tumors? Learn more: bit.ly/Alliance-A0219… #bronchialcancer #NCI #NCTN .@eaonc](https://pbs.twimg.com/media/GL7xFSgWMAEf1Af.png)
![National Cancer Institute(@theNCI) 's Twitter Profile Photo National Cancer Institute(@theNCI) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/883052294945865729/1TckZQzv_200x200.jpg)
Cancer prevention is action taken to lower the chance of getting cancer. Many things in our genes, our lifestyle, and our environment may increase or decrease our risk of getting cancer. spr.ly/6010w4fZr #CancerPreventionandEarlyDetectionMonth #CancerResearch
![National Cancer Institute (@theNCI) on Twitter photo 2024-04-16 12:18:00 Cancer prevention is action taken to lower the chance of getting cancer. Many things in our genes, our lifestyle, and our environment may increase or decrease our risk of getting cancer. spr.ly/6010w4fZr #CancerPreventionandEarlyDetectionMonth #CancerResearch Cancer prevention is action taken to lower the chance of getting cancer. Many things in our genes, our lifestyle, and our environment may increase or decrease our risk of getting cancer. spr.ly/6010w4fZr #CancerPreventionandEarlyDetectionMonth #CancerResearch](https://pbs.twimg.com/media/GLSSrJxWoAAcgbn.jpg)
![Alliance for Clinical Trials in Oncology(@ALLIANCE_org) 's Twitter Profile Photo Alliance for Clinical Trials in Oncology(@ALLIANCE_org) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/878308920573526016/AiPxLHWi_200x200.jpg)
Post hoc analysis results from MASTER and GRIFFIN (AFT-29) trials. Plasma Cell Pete #AllianceFoundationTrials #mmsm
![Alliance for Clinical Trials in Oncology(@ALLIANCE_org) 's Twitter Profile Photo Alliance for Clinical Trials in Oncology(@ALLIANCE_org) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/878308920573526016/AiPxLHWi_200x200.jpg)
#ICYMI - .Sascha Tuchman UNC Lineberger leads Alliance for Clinical Trials in Oncology A062102-a trial that compares iberdomide maintenance therapy to disease monitoring to improve survival in pts who have received idecabtagene vicleucel for multiple #myeloma : bit.ly/Alliance-A0621… #mmsm Multiple Myeloma Hub #NCI #NCTN
![Alliance for Clinical Trials in Oncology (@ALLIANCE_org) on Twitter photo 2024-04-18 13:30:15 #ICYMI - .@stuchman1 @UNC_Lineberger leads @ALLIANCE_org A062102-a trial that compares iberdomide maintenance therapy to disease monitoring to improve survival in pts who have received idecabtagene vicleucel for multiple #myeloma: bit.ly/Alliance-A0621… #mmsm @MM_Hub #NCI #NCTN #ICYMI - .@stuchman1 @UNC_Lineberger leads @ALLIANCE_org A062102-a trial that compares iberdomide maintenance therapy to disease monitoring to improve survival in pts who have received idecabtagene vicleucel for multiple #myeloma: bit.ly/Alliance-A0621… #mmsm @MM_Hub #NCI #NCTN](https://pbs.twimg.com/media/GLc2Y3wWUAAeGBF.png)
![Ohio State Medical Oncology(@OhioStateMedOnc) 's Twitter Profile Photo Ohio State Medical Oncology(@OhioStateMedOnc) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1616548256909254656/7r75qGBW_200x200.jpg)
👏🏻Carolyn Presley, MD MHS recognized for presenting the 2023 Jimmie Holland Lecture at the Alliance for Clinical Trials in Oncology
![Ohio State Medical Oncology (@OhioStateMedOnc) on Twitter photo 2024-04-16 13:20:41 👏🏻@CPresGeriOncMD recognized for presenting the 2023 Jimmie Holland Lecture at the @ALLIANCE_org 👏🏻@CPresGeriOncMD recognized for presenting the 2023 Jimmie Holland Lecture at the @ALLIANCE_org](https://pbs.twimg.com/media/GLShBJtXsAAdDgW.jpg)
![NCI CTEP Clinical Research(@NCICTEP_ClinRes) 's Twitter Profile Photo NCI CTEP Clinical Research(@NCICTEP_ClinRes) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/950370379159175169/pPulPiOS_200x200.jpg)
Newly Activated #NCTN #Myeloma Trial: (A062102) Randomized Phase 2 Study of Iberdomide Maintenance Therapy Following Idecabtagene Vicleucel CAR-T in Multiple Myeloma Patients, led by Dr. Tuchman Sascha Tuchman UNC Lineberger Alliance for Clinical Trials in Oncology Learn more: buff.ly/4d0v0cM
![NCI CTEP Clinical Research (@NCICTEP_ClinRes) on Twitter photo 2024-04-16 14:01:11 Newly Activated #NCTN #Myeloma Trial: (A062102) Randomized Phase 2 Study of Iberdomide Maintenance Therapy Following Idecabtagene Vicleucel CAR-T in Multiple Myeloma Patients, led by Dr. Tuchman @stuchman1 @UNC_Lineberger @ALLIANCE_org Learn more: buff.ly/4d0v0cM Newly Activated #NCTN #Myeloma Trial: (A062102) Randomized Phase 2 Study of Iberdomide Maintenance Therapy Following Idecabtagene Vicleucel CAR-T in Multiple Myeloma Patients, led by Dr. Tuchman @stuchman1 @UNC_Lineberger @ALLIANCE_org Learn more: buff.ly/4d0v0cM](https://pbs.twimg.com/media/GLSqSa_WAAAx-6F.jpg)